APA (7th ed.) Citation

MP, P., MI, E., JI, A., NV, C., EG, D., KD, K., . . . IS, D. (2020). Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer. Bioscience trends, 14(1), 48. https://doi.org/10.5582/bst.2019.01279

Chicago Style (17th ed.) Citation

MP, Petrova, et al. "Neutrophil to Lymphocyte Ratio as a Potential Predictive Marker for Treatment with Pembrolizumab as a Second Line Treatment in Patients with Non-small Cell Lung Cancer." Bioscience Trends 14, no. 1 (2020): 48. https://doi.org/10.5582/bst.2019.01279.

MLA (9th ed.) Citation

MP, Petrova, et al. "Neutrophil to Lymphocyte Ratio as a Potential Predictive Marker for Treatment with Pembrolizumab as a Second Line Treatment in Patients with Non-small Cell Lung Cancer." Bioscience Trends, vol. 14, no. 1, 2020, p. 48, https://doi.org/10.5582/bst.2019.01279.